These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12171719)

  • 1. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines.
    Young JC; Lin K; Travis M; Hansteen G; Abitorabi A; Sirenko O; Murray L; Hill B
    Cytotherapy; 2001; 3(4):307-20. PubMed ID: 12171719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
    Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
    Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
    Luens KM; Travis MA; Chen BP; Hill BL; Scollay R; Murray LJ
    Blood; 1998 Feb; 91(4):1206-15. PubMed ID: 9454750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division.
    Murray LJ; Young JC; Osborne LJ; Luens KM; Scollay R; Hill BL
    Exp Hematol; 1999 Jun; 27(6):1019-28. PubMed ID: 10378891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential.
    Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA
    Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
    Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
    Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
    Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
    Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency.
    Novelli EM; Cheng L; Yang Y; Leung W; Ramírez M; Tanavde V; Enger C; Civin CI
    Hum Gene Ther; 1999 Dec; 10(18):2927-40. PubMed ID: 10609654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
    Gothot A; van der Loo JC; Clapp DW; Srour EF
    Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Engraftment of ex vivo expanded mononuclear cells from human umbilical cord blood in NOD/SCID mice].
    Xu L; Lin JY; Mao P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1243-6. PubMed ID: 18088476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential expression of a homing-related molecule repertoire among umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells].
    Zheng YZ; Zhang L; Wang HJ; Han ZC; Takahashi TA
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):736-9. PubMed ID: 15730718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
    Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
    Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.